Skip to content

HAART effective at preventing illness and death in babies

Over 50s have lower viral load, no link found to type of therapy, adherence or CD4 count

HAART not a risk factor for anaemia, but AZT, low CD4 counts are, and prognosis remains poor

Few new HIV infections occur due to people with primary infection

Once daily therapy just as effective as continued PI therapy

AIDS deaths in the HAART era examined at Paris conference

Further evidence of super-infection found in African sex workers and Swiss drug injectors

Hormonal contraceptives increase risk of HIV infection

IAS conference opens in Paris with calls for global treatment access